Skip to content

ISTAR MEDICAL

Active Public limited companyfounded 2010active for 16 yearsAvenue Sabin 6, 1300 WavreKBO/BCE: BE 0828.058.712 subsidiary of #2 company by total assets in Wavre, Health and social work sector

Board

6 directors, 1 in day-to-day management, 1 auditor, no change since May 2026
Director and managing director and cEO, permanent representative
appointed by deed of 23-02-2022
Director
current term since 31-07-2023 term until the 2026 general meeting
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 23-07-2026
Director, permanent representative
current term since 31-07-2023 term until 30-07-2027
also on the board of 25 other companies
listed in the 2025 annual accounts, filed on 23-07-2026
5 other companies bankrupt
Director
since 31-07-2023 term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
Director
since 31-07-2023 term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
Director
since 16-04-2024 term until 30-07-2027
listed in the 2025 annual accounts, filed on 23-07-2026
Statutory auditor, permanent representative
appointed by deed of 01-12-2014
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“la société est également valablement représentée par un délégué à cette gestion. La société est en outre, dans les limites de leur mandat…”
deed of 17-10-2025
Permanent representatives 2
Permanent representative, for
appointed by deed of 10-12-2013
Permanent representative, for
appointed by deed of 23-02-2022

Office holders in the KBO →

Mandates through the years

7 names, the dashed line is today

Director

Managing director and cEO, Director

Director

Director

Director

Director

Statutory auditor
LeadershipBoardRest of the term
Mandates as a list
    • Director, appointed by deed of 10-12-2013, still in office
    • Managing director and cEO, appointed by deed of 23-02-2022, still in office
    • Director, appointed by deed of 23-02-2022, still in office
    • Director, appointed by deed of 02-03-2023, still in office
    • Director, from 31-07-2023 to date
    • Director, from 31-07-2023 to date
    • Director, from 16-04-2024 to date
    • Statutory auditor, appointed by deed of 01-12-2014, still in office
With Starter you also see 15 former office holders in the mandate history. See plans →

Control

Consolidating parent
US
consolidates
This company
ISTAR MEDICAL
Equity -€23.5m
Loss €21.0m in 2025

and 6 other shareholders

Capital

Capital
€84,277,306.56
Shares
226,527 in the deed of 18-11-2021
Source
deed of 30-06-2026

Owners through the years

as the annual accounts name them
16%
14.51%
13.99%
12.75%
2.34%
0.7%
12.03% until 2021
0.8% until 2020
4.51% until 2017
consolidates until 2013
Owners as a list
    • 2013 to 2015: 23%
    • 2016: 21.7%
    • 2017 to 2018: 21.2%
    • 2019 to 2021: 14.2%
    • 2022 to 2024: 11.6%
    • 2025: 16%
    • 2022: 14.51%
    • 2025: 14.51%
    • 2017 to 2018: 12.53%
    • 2019 to 2020: 11.72%
    • 2025: 13.99%
    • 2025: 12.75%
    • 2014: 2.29%
    • 2015: 3.35%
    • 2016: 4.19%
    • 2017 to 2019: 2.92%
    • 2020 to 2021: 2.86%
    • 2022 to 2025: 2.34%
    • 2021 to 2022: 80%
    • 2023 to 2024: 0.8%
    • 2025: 0.7%
    • 2014 to 2015: 20.09%
    • 2016: 19.22%
    • 2017: 18.79%
    • 2018: 18.57%
    • 2019 to 2021: 12.03%
    • 2016 to 2017: 0.84%
    • 2018: 1.24%
    • 2019 to 2020: 0.8%
    • 2017: 4.51%

Source: parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 20-05-2026 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At most 7 directors
deed of 20-05-2026 (in French)
Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
Prix de Souscription Initial plus dividendes accumulés mais non versés divisé par Prix de Souscription Initial, tout titulaire d'Actions Privilégiées de Classe…
deed of 20-05-2026 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Mêmes termes et conditions y compris déclarations et garanties de l'Offre d'Acquisition au tiers, 10.8 Obligation de suite
deed of 02-09-2019 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 15:00
deed of 20-05-2026 (in French)

Shareholders

7 owners

Owners 7

  • USconsolidating parent
    consolidates
  • Equity €15.4m Loss of €8.4m in 2025 (loss of €6.5m in 2024) Checked score
    Sourceaccounts 2025
    16%
  • Equity €1.35bn Profit of €124.1m in 2025
    Sourceaccounts 2025
    14.51%
  • Equity €11.45bn Profit of €290.9m in 2025 (profit of €315.2m in 2024)
    Sourceaccounts 2025
    13.99%
  • Equity €4.98bn Profit of €151.2m in 2025 (profit of €279.8m in 2024)
    Sourceaccounts 2025
    12.75%
  • Equity €12.9m Profit of €3.0m in 2025 (profit of €3.1m in 2024) Checked score
    Sourceaccounts 30-06-2025
    2.34%
  • Equity €23.6m Profit of €444,711 in 2025 (profit of €16.6m in 2024) Checked score
    Sourceaccounts 2025
    0.7%

Capital transactions

Shareholders according to the deeds
After 4 capital increases deed of 23-02-2022 ↗
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
  • créance certaine,liquide et exigible conjointe
Stated in the deed deed of 23-02-2022 ↗
  • 563 shares
After 2 capital increases deed of 13-09-2018 ↗
After 3 capital increases deed of 27-07-2017 ↗
  • 5,750 shares
  • 4,375 shares
  • 625 shares
  • 625 shares
  • 6,250 shares
  • 2,500 shares
  • 625 shares
  • 3,375 shares
  • 375 shares
  • 250 shares
  • 250 shares
  • 3,375 shares
Share transfer deed of 27-07-2017 ↗
  • to 3,375 shares
After the capital increase deed of 05-01-2015 ↗
  • 5,000 shares
  • 6,666 shares
  • 833 shares
  • 834 shares
Show 2 older mentions
After 4 capital increases deed of 10-12-2013 ↗
  • créance (Promissory Note)
At incorporation deed of 04-08-2010 ↗
  • 19,999 shares (100%)
  • 1 share (0%)
Capital over time
  1. 30-06-2026 Capital increase of €1,500,000 · to €84,277,306.56 · 44,117 new shares at €34 per share · in cash
  2. 20-05-2026 Capital increase of €1,000,000 · to €49,141,860.16 · 29,411 new shares at €34 per share · in cash
  3. 20-05-2026 Capital increase of €502,082.20 · to €49,643,942.36 · 21,094 new shares · “apport de créance certaine,liquide et exigible par Apporteurs Privilégiés”
  4. 20-05-2026 Capital increase of €2,020.20 · to €49,645,962.36 · 202,020 new shares · in cash
  5. 20-05-2026 Capital increase of €33,131,344 · to €82,777,306.56 · 974,451 new shares · “apport par Apporteurs Ordinaires d’une créance certaine,liquide et exigible détenue chacun respectivement à l’encontre de la Société”
  6. 09-01-2026 Capital increase of €3,057,487 · to €48,141,860.16 · 277,953 new shares at €11 per share · in cash
  7. 28-11-2025 Capital increase of €1,033,105 · 93,918 new shares · in cash
  8. 28-11-2025 Capital increase of €57,060 · 563 new shares · in cash
Show 30 older capital entries
  1. 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares at €11 per share · in cash
  2. 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares at €11 per share · in cash
  3. 17-10-2025 Capital increase of €2,000,000 · to €43,994,208.16 · 181,818 new shares
  4. 02-03-2023 Capital increase of €31,356 · to €41,994,208.16 · 603 new shares at €52 per share · in cash
  5. 08-08-2022 Capital increase of €41,031,652.98 · to €41,962,852.16 · in cash
  6. 23-02-2022 Capital increase of €1,731.22 · 563 new shares
  7. 23-02-2022 Capital increase of €76,868.85 · to €773,439.38 · 24,998 new shares · “apport créance certaine,liquide et exigible”
  8. 23-02-2022 Capital increase of €156,028.58 · to €929,467.96 · 50,741 new shares · in cash
  9. 18-11-2021 Capital stated in the deed · €696,570.53 · 226,527 shares
  10. 30-08-2021 Capital increase of €230.63 · to €696,570.53 · 75 new shares · in cash
  11. 02-09-2019 Capital increase · 38,000 new shares · conversion de 38000 droits de souscription
  12. 02-09-2019 Capital increase · to €696,339.90 · 87,500 new shares, 38.6% of the 226,452 shares after the increase
  13. 02-09-2019 Capital increase · 87,500 new shares · in cash
  14. 13-09-2018 Capital increase of €7,700,000 · to €8,006,845.02 · no new shares · from reserves
  15. 13-09-2018 Capital reduction of €7,700,000 · to €306,845.02 · to absorb losses
  16. 13-09-2018 Capital increase · to €310,427.40 · 1,165 new shares
  17. 27-07-2017 Capital increase of €76,875 · to €306,845.02 · 25,000 new shares, 25.1% of the 99,787 shares after the increase · in cash
  18. 27-07-2017 Capital increase of €5,000,000 · 25,000 new shares
  19. 27-07-2017 Capital increase of €76,875 · to €306,845.02 · 25,000 new shares
  20. 09-12-2016 Capital reduction of €6,430,000 · to €229,970.02 · to absorb losses
  21. 09-12-2016 Capital increase of €6,430,000 · no new shares · from reserves
  22. 15-04-2016 Capital increase of €10,000,000 · 50,000 new shares at €200 per share · in cash
  23. 15-04-2016 Capital increase of €5,000,000 · 25,000 new shares at €200 per share · in cash
  24. 15-04-2016 Capital increase of €5,000,000 · 25,000 new shares at €200 per share
  25. 05-01-2015 Capital increase · 13,333 new shares
  26. 10-12-2013 Capital increase · 3,120 new shares · in kind
  27. 10-12-2013 Capital increase · 26,667 new shares · in cash
  28. 10-12-2013 Capital increase · 13,334 new shares · in cash
  29. 10-12-2013 Capital increase · 13,333 new shares
  30. 04-08-2010 Incorporation · €61,500 · 20,000 shares

The directors' other companies

1 current director with another company that went bankrupt, was dissolved or struck off

5 other companies of this director went bankrupt (2011, 2017, 2021, 2022, 2025).

  • bankruptcy on 29-12-2025appointed in 2021, in office until the bankruptcy
  • bankruptcy on 02-06-2022appointed in 2015, in office until the bankruptcy
  • bankruptcy on 28-10-2021appointed in 2013, in office until the bankruptcy
  • bankruptcy on 10-04-2017appointed in 2012, in office until the bankruptcy
  • bankruptcy on 27-09-2011appointed in 2010, in office until the bankruptcy

Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.

Next steps